CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
For the period ended Sep 27, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 27, 2025 · Filed Nov 5, 2025
CRL$353.34+4.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| (a) Exhibits · Description of Exhibits · Filed with this Form 10-Q · Incorporation by Reference | |||||
|---|---|---|---|---|---|
| Form · Filing Date · Exhibit No. | |||||
| 10.1 | Amendment to the Amended and Restated Employment Agreement by and between James C. Foster and Charles River International, Inc., dated May 20, 2025 | 10-Q | August 6, 2025 | 10.1 | |
| 10.2 | Cooperation Agreement, by and among the Company and Elliott Investment Management L.P., Elliott Associates, L.P. and Elliott International, L.P., dated as of May 6, 2025 | 8-K | May 7, 2025 | 10.1 | |
| 31.1 | Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer | X | |||
| 31.2 | Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer | X | |||
| 32.1+ | Certification of the Principal Executive Officer and the Principal Financial Officer required by Rule 13a-14(a) of 15d-14(a) of the Exchange Act | X | |||
| 101.INS | eXtensible Business Reporting Language (XBRL) Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | X | |||
| 101.SCH | XBRL Taxonomy Extension Schema Document | X | |||
| 101.CAL | XBRL Taxonomy Calculation Linkbase Document | X | |||
| 101.DEF | XBRL Taxonomy Definition Linkbase Document | X | |||
| 101.LAB | XBRL Taxonomy Label Linkbase Document | X | |||
| 101.PRE | XBRL Taxonomy Presentation Linkbase Document | X | |||
| + Furnished herein. | |||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | |
| November 5, 2025 | /s/ JAMES C. FOSTER |
| James C. FosterChairman, President and Chief Executive Officer | |
| November 5, 2025 | /s/ MICHAEL G. KNELL |
| Michael G. KnellInterim Chief Financial Officer, Corporate Senior Vice President, Chief Accounting Officer(duly authorized officer and Principal Financial and Accounting Officer) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.